학술논문
Combination BRAFV600E Inhibition with the Multitargeting Tyrosine Kinase Inhibitor Axitinib Shows Additive Anticancer Activity in BRAFV600E -Mutant Anaplastic Thyroid Cancer
Document Type
Article
Author
Source
In: Thyroid . (Thyroid, 1 October 2023, 33(10):1201-1214)
Subject
Language
English
ISSN
15579077
10507256
10507256